Clincosm LogoSign in Get a demo

stage iv bladder cancer

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

Terminated
  • Bladder Cancer
  • +4 more
  • 3D conformal radiation therapy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 14, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

Recruiting
  • Stage II Breast Cancer
  • +22 more
  • Behavioral Intervention
  • Bay City, Michigan
  • +7 more
Sep 29, 2021

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
Has Results
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
Has Results
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
Sep 17, 2020

Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Canada, Israel, United States (Intensity-Modulated Radiation Therapy)

Terminated
Has Results
  • Stage III Bladder Cancer
  • Stage IV Bladder Cancer
  • Intensity-Modulated Radiation Therapy
  • Bakersfield, California
  • +127 more
Nov 16, 2018

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
Has Results
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +6 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 26, 2018

Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)

Terminated
  • Recurrent Bladder Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 10, 2018

Recurrent Bladder Carcinoma, Stage II Bladder Cancer, Stage III Bladder Cancer Trial in Seattle (Cisplatin, Gemcitabine

Completed
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • Seattle, Washington
  • +1 more
Sep 20, 2017

Stage IV Bladder Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
  • Stage IV Bladder Cancer
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Sep 26, 2017

Recurrent Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Belgium, France

Completed
  • Recurrent Bladder Cancer
  • +2 more
  • Trastuzumab
  • +3 more
  • Bruxelles, Belgium
  • +14 more
Feb 3, 2017

Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial (doxorubicin HCl,

Completed
  • Stage III Bladder Cancer
  • +2 more
  • doxorubicin hydrochloride
  • +5 more
  • (no location specified)
Aug 1, 2016

Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma Trial in New Brunswick (biological,

Terminated
  • Bladder Adenocarcinoma
  • +7 more
  • Recombinant Fowlpox-TRICOM Vaccine
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Dec 22, 2014

Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial

Terminated
Has Results
  • Adenocarcinoma of the Bladder
  • +12 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 20, 2014

Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Transitional Cell Cancer of

Terminated
  • Advanced Adult Primary Liver Cancer
  • +13 more
  • gemcitabine hydrochloride
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 1, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +9 more
  • San Francisco, California
    UCSF-Mount Zion
Jun 4, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Terminated
  • Distal Urethral Cancer
  • +8 more
  • trastuzumab
  • Chicago, Illinois
    Cancer and Leukemia Group B
May 1, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer Trial in Los Angeles (decitabine, pharmacological study,

Completed
  • Male Breast Cancer
  • +8 more
  • Los Angeles, California
    University of Southern California
Feb 6, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
  • Distal Urethral Cancer
  • +10 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 23, 2013

Recurrent Bladder Cancer, Stage I Bladder Cancer, Stage II Bladder Cancer Trial in Houston (Ad5CMV-p53 gene)

Completed
  • Recurrent Bladder Cancer
  • +5 more
  • Ad5CMV-p53 gene
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +5 more
  • trastuzumab
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jan 11, 2013